Nula Therapeutics

Seed
nulatx.com Biotech & Healthcare St. Petersburg, United States
Total Funding $20M
Latest Round $20M Seed
Last Announced Mar 18, 2026
Investors Undisclosed
Decision Makers 1 Verified

About Nula Therapeutics

Nula Therapeutics pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters St. Petersburg, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website nulatx.com
Domain Registered Date May 20, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $20,000,000 · Seed

    news.google.com

  2. Milestone

    Website domain registered

    nulatx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Nula Therapeutics.

Funding History

1 Round
Seed equity · Mar 18, 2026
$20,000,000 news.google.com

Founders & Leadership

1

Christopher Shepard

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts